UroGen Pharma Ltd.
DE ˙ DB ˙ IL0011407140
€23,18 ↑0,82 (3,67%)
2026-06-05
HİSSE FİYATI
SecurityDE:UR8 / UroGen Pharma Ltd.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in UR8 / UroGen Pharma Ltd.

On August 14, 2025 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of UroGen Pharma Ltd. (DE:UR8) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR on May 14, 2025 disclosing 25,350 shares of UroGen Pharma Ltd.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (UR8) in the form of stock options. The firm currently holds call options representing 73,000 of underlying shares valued at $1,709,660 USD and put options representing 37,900 of underlying shares valued at $887,618 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:UR8 / UroGen Pharma Ltd. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-14 2025-06-30 13F UROGEN PHARMA COM M96088105 0 -25,350 -100.00 0 -100.00
2025-05-14 2025-03-31 13F UROGEN PHARMA COM M96088105 25,350 23,961 1,725.05 280 1,900.00 0.0008
2025-05-14 2024-12-31 13F/A-1 UROGEN PHARMA COM M96088105 1,389 -6,385 -82.13 15 -85.71 0.0000
2025-02-14 2024-12-31 13F UROGEN PHARMA COM M96088105 1,389 -6,385 15 0.0000
2024-11-14 2024-09-30 13F UROGEN PHARMA COM M96088105 7,774 -1,515 -16.31 99 -36.77 0.0003
2024-08-14 2024-06-30 13F UROGEN PHARMA COM M96088105 9,289 9,289 156 0.0006
2024-05-10 2024-03-31 13F UROGEN PHARMA COM M96088105 0 -100 -100.00 0 -100.00
2024-02-14 2023-12-31 13F UROGEN PHARMA COM M96088105 100 100 2 0.0000
2022-05-11 2022-03-31 13F UROGEN PHARMA COM M96088105 0 -14,036 -100.00 0 -100.00
2022-02-11 2021-12-31 13F UROGEN PHARMA COM M96088105 14,036 -29,592 -67.83 133 -81.88 0.0001
2021-11-12 2021-09-30 13F UROGEN PHARMA COM M96088105 43,628 -9,146 -17.33 734 -8.93 0.0008
2021-08-10 2021-06-30 13F UROGEN PHARMA COM M96088105 52,774 -35,825 -40.43 806 -53.30 0.0010
2021-05-12 2021-03-31 13F UROGEN PHARMA COM M96088105 88,599 -41,142 -31.71 1,726 -26.18 0.0026
2021-02-10 2020-12-31 13F UROGEN PHARMA COM M96088105 129,741 -25,169 -16.25 2,338 -21.75 0.0040
2020-11-12 2020-09-30 13F UROGEN PHARMA COM M96088105 154,910 90,038 138.79 2,988 76.39 0.0094
2020-08-13 2020-06-30 13F UROGEN PHARMA COM M96088105 64,872 42,930 195.65 1,694 333.25 0.0078
2020-05-13 2020-03-31 13F UROGEN PHARMA COM M96088105 21,942 -6,154 -21.90 391 -58.32 0.0032
2020-02-10 2019-12-31 13F UROGEN PHARMA COM M96088105 28,096 28,096 938 0.0064
2019-02-05 2018-12-31 13F UROGEN PHARMA COM M96088105 0 -180 -100.00 0 -100.00
2018-11-08 2018-09-30 13F UROGEN PHARMA COM M96088105 180 180 9 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F UROGEN PHARMA COM Call 73,000 -36.74 1,710 -25.76 n/a n/a n/a
2025-11-12 2025-09-30 13F UROGEN PHARMA COM Call 115,400 -61.55 2,302 -44.00 n/a n/a n/a
2025-08-14 2025-06-30 13F UROGEN PHARMA COM Call 300,100 433.04 4,111 560.93 n/a n/a n/a
2025-05-14 2025-03-31 13F UROGEN PHARMA COM Call 56,300 1,097.87 623 1,144.00 n/a n/a n/a
2025-05-14 2024-12-31 13F/A UROGEN PHARMA COM Call 4,700 161.11 50 127.27 n/a n/a n/a
2025-02-14 2024-12-31 13F UROGEN PHARMA COM Call 4,700 50 n/a n/a n/a
2024-11-14 2024-09-30 13F UROGEN PHARMA COM Call 1,800 -90.27 23 -92.90 n/a n/a n/a
2024-08-14 2024-06-30 13F UROGEN PHARMA COM Call 18,500 413.89 310 474.07 n/a n/a n/a
2024-05-10 2024-03-31 13F UROGEN PHARMA COM Call 3,600 3,500.00 54 5,300.00 n/a n/a n/a
2024-02-14 2023-12-31 13F UROGEN PHARMA COM Call 100 -99.03 2 -99.31 n/a n/a n/a
2023-11-09 2023-09-30 13F UROGEN PHARMA COM Call 10,300 80.70 144 148.28 n/a n/a n/a
2023-08-09 2023-06-30 13F UROGEN PHARMA COM Call 5,700 200.00 59 241.18 n/a n/a n/a
2023-05-12 2023-03-31 13F UROGEN PHARMA COM Call 1,900 280.00 18 325.00 n/a n/a n/a
2023-02-09 2022-12-31 13F UROGEN PHARMA COM Call 500 -16.67 4 -92.00 n/a n/a n/a
2022-11-09 2022-09-30 13F UROGEN PHARMA COM Call 600 50 n/a n/a n/a
2022-02-11 2021-12-31 13F UROGEN PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F UROGEN PHARMA COM Call 50,000 0.00 841 10.08 n/a n/a n/a
2021-08-10 2021-06-30 13F UROGEN PHARMA COM Call 50,000 -41.11 764 -53.81 n/a n/a n/a
2021-05-12 2021-03-31 13F UROGEN PHARMA COM Call 84,900 -25.26 1,654 -19.20 n/a n/a n/a
2021-02-10 2020-12-31 13F UROGEN PHARMA COM Call 113,600 -20.06 2,047 -25.32 n/a n/a n/a
2020-11-12 2020-09-30 13F UROGEN PHARMA COM Call 142,100 1.36 2,741 -25.15 n/a n/a n/a
2020-08-13 2020-06-30 13F UROGEN PHARMA COM Call 140,200 385.12 3,662 609.69 n/a n/a n/a
2020-05-13 2020-03-31 13F UROGEN PHARMA COM Call 28,900 76.22 516 -5.67 n/a n/a n/a
2020-02-10 2019-12-31 13F UROGEN PHARMA COM Call 16,400 547 n/a n/a n/a
2019-05-14 2019-03-31 13F/A UROGEN PHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-02-05 2018-12-31 13F UROGEN PHARMA COM Call 100 4 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F UROGEN PHARMA COM Put 37,900 -49.13 888 -40.31 n/a n/a n/a
2025-11-12 2025-09-30 13F UROGEN PHARMA COM Put 74,500 -34.93 1,486 -5.23 n/a n/a n/a
2025-08-14 2025-06-30 13F UROGEN PHARMA COM Put 114,500 2,502.27 1,569 3,166.67 n/a n/a n/a
2025-05-14 2025-03-31 13F UROGEN PHARMA COM Put 4,400 -58.88 49 -57.52 n/a n/a n/a
2025-05-14 2024-12-31 13F/A UROGEN PHARMA COM Put 10,700 -37.06 114 -47.44 n/a n/a n/a
2025-02-14 2024-12-31 13F UROGEN PHARMA COM Put 10,700 114 n/a n/a n/a
2024-11-14 2024-09-30 13F UROGEN PHARMA COM Put 17,000 157.58 216 95.45 n/a n/a n/a
2024-08-14 2024-06-30 13F UROGEN PHARMA COM Put 6,600 111 n/a n/a n/a
2024-05-10 2024-03-31 13F UROGEN PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F UROGEN PHARMA COM Put 800 -72.41 12 -70.00 n/a n/a n/a
2023-11-09 2023-09-30 13F UROGEN PHARMA COM Put 2,900 41 n/a n/a n/a
2022-02-11 2021-12-31 13F UROGEN PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-12 2021-09-30 13F UROGEN PHARMA COM Put 50,000 0.00 841 10.08 n/a n/a n/a
2021-08-10 2021-06-30 13F UROGEN PHARMA COM Put 50,000 -41.11 764 -53.81 n/a n/a n/a
2021-05-12 2021-03-31 13F UROGEN PHARMA COM Put 84,900 -64.61 1,654 -61.74 n/a n/a n/a
2021-02-10 2020-12-31 13F UROGEN PHARMA COM Put 239,900 19.77 4,323 11.88 n/a n/a n/a
2020-11-12 2020-09-30 13F UROGEN PHARMA COM Put 200,300 43.07 3,864 5.66 n/a n/a n/a
2020-08-13 2020-06-30 13F UROGEN PHARMA COM Put 140,000 319.16 3,657 513.59 n/a n/a n/a
2020-05-13 2020-03-31 13F UROGEN PHARMA COM Put 33,400 -42.81 596 -69.42 n/a n/a n/a
2020-02-10 2019-12-31 13F UROGEN PHARMA COM Put 58,400 1,949 n/a n/a n/a
2019-02-05 2018-12-31 13F UROGEN PHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-08 2018-09-30 13F UROGEN PHARMA COM Put 100 5 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.